|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.3 EUR | +0.81% |
|
-1.88% | -26.07% |
| Apr. 04 | DERMAPHARM : Berenberg keeps its Buy rating | ZD |
| Mar. 28 | Dermapharm Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Dermapharm Holding SE reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was EUR 876.6 million compared to EUR 745.22 million a year ago. Net income was EUR 65.06 million compared to EUR 104.35 million a year ago.
Basic earnings per share from continuing operations was EUR 1.21 compared to EUR 1.94 a year ago. Diluted earnings per share from continuing operations was EUR 1.21 compared to EUR 1.94 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.07% | 1.8B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
DERMAPHARM HOLDING SE 
